Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
You are in: eMedicine Specialties > Emergency Medicine > Endocrine And Metabolic

Hypopituitarism

Last Updated: November 9, 2006
Email to a Colleague
Synonyms and related keywords: hypopituitarism, pituitary apoplexy, Sheehan's syndrome, Sheehan syndrome, pituitary hormone deficiencies, thyrotropin, thyroid-stimulating hormone, TSH, gonadotropins, follicle-stimulating hormone, FSH, luteinizing hormone, LH, growth hormone, GH, corticotropin, adrenocorticotropic hormone, ACTH, prolactin hormone, PRL, traumatic brain injury, TBI, cocaine snorting, subarachnoid hemorrhage, postpartum hypotension, pituitary insufficiency

  AUTHOR INFORMATION Section 1 of 10    Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Author: Jerome FX Naradzay, MD, FACEP, Emergency Services Medical Director, Department of Emergency Medicine, Maria Parham Medical Center

Coauthor(s): Stuart A Brilliant, MD, Staff Physician, Department of Emergency Medicine, University of Connecticut

Jerome FX Naradzay, MD, FACEP, is a member of the following medical societies: American College of Emergency Physicians, and Society for Academic Emergency Medicine

Editor(s): Erik D Schraga, MD, Consulting Staff, Permanente Medical Group, Kaiser Permanente, Santa Clara Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Howard A Bessen, MD, Professor of Medicine, UCLA School of Medicine; Program Director, Department of Emergency Medicine, Harbor-UCLA Medical Center; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital

Disclosure


  INTRODUCTION Section 2 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Background: The diagnosis of hypopituitarism is easily overlooked as the symptoms and signs are frequently protean and nonspecific, including alterations in electrolyte levels, mental status, glucose levels, body temperature, and heart rate. The setting is not uncommon in which an emergency physician is evaluating a patient with complaints of weakness, fatigue, or altered mental status without a clear diagnosis. Subtle, but still abnormal vital signs, such as slightly reduced blood pressure or heart rate may be the only initial clues to suggest a pituitary deficiency rather than a relatively benign etiology.

Awareness and clinical recognition of the diagnosis is vital, given that emergency physicians frequently provide care to patients at risk of developing hypopituitarism such those with traumatic brain injury (TBI), cocaine snorting, subarachnoid hemorrhage, and postpartum hypotension (Sheehan syndrome).

The physician must be vigilant to consider hypopituitarism as the cause for otherwise unexplained abnormal laboratory values and vital signs.

The pituitary gland was first called "hypophysis" by Thomas Soemmering in 1778. Hypophysis is a Greek term that describes how the pituitary appears to "grow beneath the brain."

The pituitary gland carries the respectable sobriquet "master gland" because it produces hormones that regulate growth, development, and reproduction.

Despite its vital role, the pituitary gland is merely the size of a small pea. It is located in the middle cranial fossa within a recess of the sphenoid bone called the sella turcica ("Turks saddle").

The gland has two parts: the anterior pituitary (adenohypophysis) and the posterior pituitary (neurohypophysis).

The anterior pituitary receives signals from the hypothalamus that either stimulate or inhibit secretion of pituitary hormones. These hormones are secreted directly into the systemic circulation, where they act upon specific organs.

The actions of the pituitary gland can be modulated at many stages. The pituitary hormones, or target organ hormones, can influence both the hypothalamus and the pituitary to decrease or increase pituitary hormone secretion through long and short feedback loops. Hormones secreted by the anterior pituitary include the following:

  • Thyrotropin, or thyroid-stimulating hormone (TSH)

  • Gonadotropins, or follicle-stimulating hormone (FSH) and luteinizing hormone (LH)

  • Growth hormone (GH)

  • Corticotropin, or adrenocorticotropic hormone (ACTH)

  • Prolactin hormone (PRL)

The posterior pituitary does not produce its own hormones. The hypothalamus produces two hormones, vasopressin (VP) and oxytocin (OXT), that are secreted into the capillary beds that supply the posterior pituitary, where they are ultimately released into circulation.

Vasopressin primarily acts on the V2 receptors of the distal tubules of the kidney to reabsorb water, which increases total body water and urine osmolality. Vasopressin also acts as a pressor on the V1 receptors of vascular smooth muscle. Oxytocin induces labor in pregnant women, causing contraction of uterine smooth muscle; the hormone also initiates the mechanics of breastfeeding.

Pathophysiology: Common causes of pituitary insufficiency include pituitary adenomas or other intrasellar and parasellar tumors, inflammatory destruction, surgical removal, radiation-induced destruction of pituitary tissue, traumatic brain injury (TBI), subarachnoid hemorrhage, and postpartum pituitary necrosis (Sheehan syndrome).

Pituitary tumors, or adenomas, are the most common cause of hypopituitarism in adults. Depletion of pituitary function by tumors occurs via the following 3 mechanisms:

  • In primary pituitary destruction (intrinsic pituitary destruction), the hormone-secreting cells of the anterior pituitary are destroyed. This condition can involve some or all pituitary hormones.

  • Intrinsic hypothalamic disease involves compression or destruction of the hypothalamus. This condition causes a deficiency or loss of hypothalamic regulatory hormones and impairs anterior pituitary hormone secretion.

  • Extrinsic diseases destroy the hypothalamus, the pituitary stalk, or the anterior pituitary gland.

Pituitary tumors, or adenomas, can be secretory or nonsecretory. Approximately 30% of all macroadenomas larger than 10 mm will produce at least one hormone.

Frequency:

  • In the US: Although the prevalence of pituitary adenomas is strikingly high (10-20%) in autopsy and MRI studies, the actual presence of clinical disease is quite uncommon. Approximately 2-8 in 100,000 persons per year present with symptoms attributed to pituitary tumors.

Mortality/Morbidity: The systemic effects of pituitary hormone deficiencies vary depending on the extent of pituitary involvement. Given that the pituitary acts on numerous endocrine sites, the consequences of pituitary dysfunction range from mild single-system disease to panhypopituitarism.

  • Missed or delayed diagnosis could potentially lead to permanent disability or death.
  • Female patients with hypopituitarism receiving controlled thyroid and steroid hormone substitution, but without growth hormone replacement, have more than a 2-fold increase in cardiovascular mortality compared with the general population.
  • Cardiovascular disease is significantly higher among hypopituitary patients (incidence ratio, 3.7; 95% confidence interval, 1.2–11.3).

  • Hypopituitary patients have lower high-density lipoprotein cholesterol (P = 0.002) and higher low-density/high-density lipoprotein ratio (P = 0.009).

Sex:

  • The most frequent etiologies of hypopituitarism do not demonstrate a significant disparity in incidence between genders. Postpartum pituitary necrosis (Sheehan syndrome) is clearly only seen among female patients.


  CLINICAL Section 3 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

History: Symptom presence and severity depend on the amount of and rapidity of hormone depletion. Clinical manifestations closely match those of primary deficiency or hypofunctioning of target glands. Hypopituitarism is usually a combination of several hormonal deficiencies and rarely involves all pituitary hormones. End-organ hormonal insufficiencies are referred to as secondary deficiencies of the target organ (eg, hypothyroidism caused by a decrease in TSH will be termed secondary hypothyroidism).

The presence of an antecedent closed head injury may be elicited. Patients with traumatic brain injury can have some degree of hypopituitarism as soon as 3 months and typically by 12 months following the injury. Nearly all patients with resultant pituitary deficiency will have experienced loss of consciousness following the trauma, and approximately half have a skull fracture.

  • The onset of hypopituitarism is often gradual over a period of years, but in some conditions, rapid onset is seen. The insidious decline in health is often attributed to other medical conditions prior to recognition.
  • Adrenocorticotropic hormone deficiency
    • Deficiency in corticotropin is characterized by a decrease in adrenal androgens and production of cortisol.

    • Acute loss of adrenal function is a medical emergency and may lead to hypotension and death if not treated.

    • Signs and symptoms of ACTH deficiency may be profound and potentially fatal and include myalgias, arthralgias, fatigue, headache, weight loss, anorexia, nausea, vomiting, abdominal pain, altered mentation or altered consciousness, dry wrinkled skin, decreased axillary and pubic hair, anemia of chronic disease, dilutional hyponatremia, hypoglycemia, hypotension, and shock.

    • Symptoms are nearly identical to those of primary adrenal insufficiency but can be differentiated by lack of hyperpigmentation. Hyperpigmentation occurs in a long feedback loop in which a cortisol deficiency results in increased production of ACTH by the pituitary. The ACTH precursor coupled to melanocyte-stimulating hormone is not produced in those with pituitary disease, and therefore hyperpigmentation does not take place.

    • Patients with secondary adrenal sufficiency usually are eukalemic. This differs from primary adrenal insufficiency, in which patients develop hyponatremia and hyperkalemia.

    • Aldosterone secretion is not affected, as it does not depend on corticotropin but instead on the renin-angiotensin axis.
  • Thyrotropin deficiency
    • Secondary thyrotropin deficiency (ie, hypothyroidism) due to decreased TSH exhibits identical symptoms to primary thyroid disease, only typically less severe.

    • Signs and symptoms of secondary hypothyroidism include fatigue, weakness, weight gain, thickened subcutaneous tissues, constipation, cold intolerance, altered mental status, impaired memory, and anemia.

    • Physical examination may reveal bradycardia, delayed relaxation of the deep tendon reflexes, and periorbital edema.
  • Gonadotropin deficiency
    • Low FSH and LH levels increase risk of osteoporosis due to decreased bone density and result in hypogonadism in both men and women.

    • In men, symptoms include decreased libido, varying degrees of erectile dysfunction, decreased ejaculate, muscle weakness, and fatigue.

    • Men with long-standing hypogonadism have decreased hair growth, soft testes, and gynecomastia.

    • Patients may be anemic due to decreased erythropoietin production, which causes a normochromic, normocytic anemia.

    • Premenopausal women present with altered menstrual function, ranging from regular anovulatory periods to amenorrhea, hot flashes, decreased libido, breast atrophy, vaginal dryness, and dyspareunia.

    • Pubic and axillary hair growth is usually normal unless a concomitant ACTH deficiency exists.

    • Postmenopausal women usually present with headache or visual abnormalities due to other hormonal deficiencies or mass lesions.

    • In children, FSH and LH deficiency can cause eunuchoidism and lack of sexual development.

      • FSH and LH have an indirect effect on bone growth by causing closure of the epiphysis.

      • Characteristics of eunuchoidism are due to delay in closure of the epiphysis, resulting in long extremities.
  • Growth hormone deficiency
    • In children, GH deficiency presents as growth retardation and delayed sexual maturation.

    • Patients may present with fasting hypoglycemia due to loss of the gluconeogenic effect of GH, which counteracts the effect of insulin.

    • In adults, GH deficiency presents as weakness, poor wound healing, decreased exercise tolerance, and decreased social functioning.
  • Prolactin deficiency
    • Tumor growth that decreases PRL production affects the process of lactation; these tumors become evident only in the postpartum state.

    • PRL deficiency is very rare; any process that affects the hypothalamus and the pituitary stalk decreases the normal inhibitory effect of dopamine from the hypothalamus on the pituitary, causing a rebound increase in PRL.
  • Antidiuretic hormone deficiency
    • Antidiuretic hormone (ADH) deficiency causes polyuria and polydipsia (diabetes insipidus).

    • When deficient in ADH, the distal tubules of the kidney are unable to absorb water, producing very dilute urine and increasing serum osmolality.

    • If water excretion exceeds oral intake, a patient may become hypotensive and hypovolemic with hypernatremia and elevated serum osmolality.

    • If fluid intake matches fluid output, serum sodium and osmolality may remain normal.
    • Central diabetes insipidus is caused by a decrease in ADH secretion, in contrast to nephrogenic diabetes insipidus, in which the kidney is ADH resistant.
  • Oxytocin deficiency
    • Deficiency in oxytocin is characterized by a decrease in milk ejection during lactation. Interestingly, women with known oxytocin deficiency undergo normal labor and delivery despite the lack of hormone.
    • One of the initial clues to the presence of Sheehan syndrome should be the lack of lactation secondary to oxytocin deficiency.

Physical: A complete physical examination including thyroid palpation, genital inspection, and visual examination (particularly visual field testing) is essential in the setting of protean complaints, electrolyte abnormalities, a history of traumatic brain injury, lack of postpartum lactation and menstrual irregularity.

During both the neurologic and ophthalmic examinations, check specifically for visual acuity, extraocular movements, and bitemporal hemianopsia. (See the above discussion for signs that are consistent with each of the abnormal hormonal states.)

Causes:

  • Hypopituitarism resulting from pituitary adenomas is due to impaired blood flow to the normal tissue, compression of normal tissue, or interference with the delivery of hypothalamic hormones via the hypothalamus-hypophysial portal system.
    • Hypersecretion of the secretory pituitary tumor hormone is suggestive of an adenoma.
    • Another indication of a pituitary adenoma is a deficiency in some pituitary hormones with concomitant hyperprolactinemia. Normally, dopamine, produced in the hypothalamus, inhibits prolactin secretion by the anterior pituitary. Compressing the pituitary stalk decreases the inhibitory effect of dopamine and increases prolactin levels.
  • Another common intracranial tumor is craniopharyngioma, a squamous cell tumor that arises from remnants of the Rathke pouch. One third of these tumors extend into the sella, while approximately two thirds remain suprasellar.
  • Sheehan syndrome occurs with large volume of postpartum hemorrhage.
    • During pregnancy, the pituitary gland enlarges due to hyperplasia and hypertrophy of the lactotroph cells, which produce prolactin. The hypophyseal vessels, which supply the pituitary, constrict in response to decreasing blood volume, and subsequent vasospasm occurs, causing necrosis of the pituitary gland. The degree of necrosis correlates with the severity of the hemorrhage.
    • As many as 30% of women experiencing postpartum hemorrhage with hemodynamic instability may develop some degree of hypopituitarism. These patients can develop adrenal insufficiency, hypothyroidism, amenorrhea, diabetes insipidus, and an inability to breastfeed.
  • Pituitary apoplexy denotes the sudden destruction of the pituitary tissue resulting from infarction or hemorrhage into the pituitary.
    • The most likely cause of the apoplexy is brain trauma; however, it can occur in patients with diabetes mellitus, pregnancy, sickle cell anemia, blood dyscrasias or anticoagulation, and increased intracranial pressure.
    • Apoplexy usually spares the posterior pituitary and solely affects the anterior pituitary.
  • Head trauma from a motor vehicle accident, a fall, or a projectile can cause hypopituitarism by direct damage to the pituitary or by injuring the pituitary stalk or the hypothalamus. Hypopituitarism may occur immediately, or it may develop months or years later. Recovery is uncommon.
  • Other causes of hypopituitarism include empty sella syndrome and infiltrative diseases.
    • Empty sella syndrome occurs when the arachnoid herniates into the sella turcica through an incompetent sellar diaphragm and flattens the pituitary against bone.
    • Infiltrative diseases, such as Wegener granulomatosis and sarcoidosis, can cause destruction of the anterior pituitary.
  • Physiologic or psychological states can influence the hypothalamic-pituitary stalk by impairing synthesis and secretion of regulating hormones.
    • The degree of the deficiency varies greatly and depends on the extent of the process and its location.
    • Some functional causes include emotional disorders, changes in body weight, habitual exercise, anorexia, bulimia, congestive heart failure (CHF), renal failure, and certain medications.
  DIFFERENTIALS Section 4 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Adrenal Insufficiency and Adrenal Crisis
Hypothyroidism and Myxedema Coma
Shock, Cardiogenic
Shock, Septic


Other Problems to be Considered:

Chronic liver disease
Myotonia dystrophica
Primary psychosis
Primary hypogonadism

Quick Find
Author Information
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Bibliography

Click for related images.

Related Articles
Adrenal Insufficiency and Adrenal Crisis

Hypothyroidism and Myxedema Coma

Shock, Cardiogenic

Shock, Septic


Patient Education



  WORKUP Section 5 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Lab Studies:

  • Laboratory and radiographic tests are necessary to confirm the diagnosis.

  • A variety of laboratory tests can be used, but significant controversy exists regarding which tests are ideal.

  • Because many specific endocrine tests are not rapidly available in the ED setting, immediate confirmation of hypopituitarism may not be practical. Clinical suspicion by history and clinical examination may be the only tools to reveal the etiology and to guide appropriate endocrine follow-up care.

  • Expensive, time-consuming tests, which may be performed and interpreted upon follow-up by endocrinologists, are listed below.

  • Corticotropin deficiency may be evident with the finding of a decreased serum cortisol level.
    • A low cortisol level may not help to distinguish primary adrenal insufficiency from secondary adrenal insufficiency due to hypopituitarism. The conditions can be differentiated on clinical grounds. A patient with secondary causes due to pituitary dysfunction will have relatively pale complexion, a normal aldosterone response, and low ACTH.

    • The opposite is true for primary adrenal insufficiency. Hyperpigmentation in primary adrenal insufficiency is due to increased ACTH production with concomitant overproduction of melanocyte-stimulating hormone, which is coupled ACTH in a mutual precursor.

    • ACTH deficiency in the morning during its highest circadian levels suggests a pituitary/hypothalamic etiology.
  • The corticotropin stimulation test, which evaluates the hypothalamic-pituitary-adrenal axis, is a superior tool in distinguishing hypopituitarism from primary adrenal insufficiency.
    • This dynamic test measures serum cortisol before and after a 250-mcg dose of ACTH.

    • The cortisol level should at least double 30-60 minutes after ACTH administration in those with normal adrenal function.

    • A low cortisol level that fails to rise after ACTH administration represents an abnormal cortisol response, a response seen in primary adrenal insufficiency. Because of adrenal atrophy, however, cortisol response is often slightly blunted in patients with hypopituitarism.
  • Assessment of thyroid function is important in the evaluation of ACTH deficiency.
    • In a hypothyroid state, cortisol clearance decreases, causing an increase in serum cortisol.

    • If thyroid replacement is initiated, cortisol level drops acutely, initiating an adrenocortical crisis.
  • In suspected thyrotropin deficiency, measure serum thyrotropin (TSH) and thyroxine (T4).
    • A normal level of total free T4 rules out hypothyroidism.

    • Low serum TSH and a small, atrophic thyroid gland confirm the diagnosis of thyrotropin deficiency.
  • LH and FSH deficiencies may indicate secondary hypogonadism.
    • Measuring LH and FSH is possible, but values range widely throughout the day and are therefore unreliable.

      • Measure multiple samples and calculate a mean value before establishing gonadotropin deficiency.

    • In men, measuring serum testosterone levels is useful.

      • Decreased testosterone should be associated with an increase in FSH and LH if pituitary function is normal. Low or normal FSH or LH in the face of low testosterone indicates hypopituitarism.

      • Semen analysis also may be performed. A normal semen sample excludes hypogonadism of a primary or secondary source.

    • Elevated FSH and LH differentiate primary hypogonadism from secondary hypogonadism.
  • GH deficiency can be confirmed by directly measuring serum levels.
    • Given that GH secretion is pulsatile, a single low serum level must be repeated for confirmation, whereas a single elevated or normal serum GH level can exclude the diagnosis of GH deficiency.
  • PRL deficiency can also be verified by directly measuring serum levels.
    • As with most other pituitary hormones, secretion of PRL is episodic; more than one value is necessary for diagnosis.

    • Testing is rarely necessary since most patients are asymptomatic.
  • A water deprivation test can help differentiate psychogenic polydipsia from diabetes insipidus.
    • Supervise patients constantly to calculate water intake, as patients with psychogenic polydipsia will often use any means possible to consume water (eg, drinking from a toilet bowl).

    • While withholding water, take blood and urine samples hourly to measure serum and urine osmolalities.

    • If the cause is psychogenic, urine osmolality increases while serum osmolality remains normal.
  • If urinary concentrations do not increase in a water deprivation test, the diagnosis of diabetes insipidus is established. Subsequently, an aqueous vasopressin stimulation test may assist in discriminating between central and nephrogenic diabetes insipidus.
    • Administer either 5 units of aqueous vasopressin, or 1-2 mcg of desmopressin (DDAVP) subcutaneously.

    • After 1 hour, acquire an additional set of serum and urine specimens and record the results.

    • An increase in urine osmolality and a decrease in serum osmolality support a central cause of diabetes insipidus and a lack of ADH.

    • If osmolalities remain unchanged, the patient has nephrogenic diabetes insipidus.

Imaging Studies:

  • Radiographic studies of the head (eg, MRI, CT scan) can be performed for patients with a history and physical examination suggestive of an intracranial lesion. Both MRI and CT scans should be ordered with intravenous contrast to increase sensitivity of the tests.
  • MRI is superior in localizing and characterizing intracranial lesions; however, CT scan may be more readily accessible.
  • A lateral skull film can delineate contours of the sella turcica but are otherwise very unlikely to provide any beneficial information.
  TREATMENT Section 6 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Prehospital Care: Vital sign abnormalities and life-threatening concerns should be managed according to prehospital protocols, such as those for hypoglycemia, altered mental status, bradycardia, or seizures (Sheehan syndrome or electrolyte deficiency).

Emergency Department Care: ED treatment of hypopituitarism focuses on acute emergencies involving hormone deficiencies and the resulting metabolic and cardiovascular disturbances.

The patient who is symptomatic from a hypopituitary condition may require multiple interventions including sodium replacement, glucose replacement, bradycardia treatment, steroid administration, and fluid resuscitation.

Upon initial presentation to the ED, most patients with hypopituitarism will not have a clear diagnosis yet established. Treatment of life-threatening conditions must occur well before the diagnosis is made.

  • Those with hypotension should be given intravenous fluids and pressors as indicated. For those with suggestion of adrenal insufficiency with refractory hypotension, the addition of steroids may be lifesaving.
  • In cases of seizures refractory to initial measures, consider hypoglycemia and hyponatremia as etiologies and treat accordingly with intravenous dextrose or 3% saline.
  • Postpartum women with hypotension and history of hemorrhage may require blood transfusion in addition to fluid repletion.

Consultations:

  • The treatment of patients with hypopituitarism is often complex because of multiple endocrine deficiencies and consequent abnormalities that require close specific laboratory testing and monitoring during treatment.
  • Patients in whom hypopituitarism is suspected require consultation with an endocrinologist to assist in management.
  • Patients with acute adrenal insufficiency due to corticotropin deficiency require admission, endocrinologist consultation, and potentially critical care evaluation.

  MEDICATION Section 7 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Medications used in hypopituitarism vary depending on the specific hormone deficiency that exists.

Drug Category: Agents for hormone replacement -- These drugs are either synthetic or natural agents used to supplement hormone deficiencies resulting from hypopituitarism.
Drug Name
Hydrocortisone (Solu-Cortef, Westcort) -- Used as steroid replacement in patients who have adrenal insufficiency. For hypotensive patients and acute management, use IV preparation.
Adult DoseOutpatient: 10 mg PO qam, 5 mg PO qpm
Inpatient: 100-250 mg IV initial bolus, followed by 100 mg IV q8h until patient is hemodynamically stable and able to take PO
Pediatric Dose0.5-0.75 mg/kg/d or 20-25 mg/m2/d PO divided q8h
ContraindicationsDocumented hypersensitivity; viral, fungal, or tubercular skin infections
Interactions Clearance may decrease with estrogens; may increase digitalis toxicity secondary to hypokalemia
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsCaution in hyperthyroidism, osteoporosis, peptic ulcer, cirrhosis, nonspecific ulcerative colitis, diabetes, and myasthenia gravis
Drug Name
Prednisone (Deltasone, Orasone, Sterapred) -- Alternative to hydrocortisone in patients with adrenal insufficiency. Medication of choice for maintenance therapy.
Adult Dose5 mg PO divided bid
Pediatric Dose4-5 mg/m2/d PO
Alternatively, administer 1-2 mg/kg PO qd
ContraindicationsDocumented hypersensitivity; viral infection; peptic ulcer disease; hepatic dysfunction; connective tissue infections; fungal or tubercular skin infections; GI disease
InteractionsEstrogens may decrease clearance; concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism (consider increasing maintenance dose); monitor for hypokalemia with concurrent diuretics
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsAbrupt discontinuation may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur
Drug Category: Thyroxine products -- These agents are used for the treatment of hypothyroidism.
Drug Name
Levothyroxine (Synthroid, Levoxyl) -- Thyroid supplement whose active form influences tissue growth and maturation. Involved in normal growth, metabolism, and development. Endocrinologists can monitor and adjust doses to optimal effect.
Adult Dose12.5-50 mcg/d PO initially; increase by 25-50 mcg/d q2-4wk; not to exceed 100-200 mcg/d
Pediatric DoseNeonate to 6 months: 25 mcg/d PO
6-12 months: 50 mcg/d PO
1-5 years: 75 mcg/d PO
6-12 years: 100 mcg/d PO
>12 years: 150 mcg/d PO
ContraindicationsDocumented hypersensitivity; uncorrected adrenal insufficiency
InteractionsCholestyramine may decrease absorption; estrogens may decrease response to thyroid hormone therapy in patients with nonfunctioning thyroid glands; increases effects of anticoagulants; activity of some beta-blockers may decrease when hypothyroid patient is converted to a euthyroid state
Pregnancy A - Safe in pregnancy
PrecautionsCaution in angina pectoris or cardiovascular disease; monitor thyroid status periodically
Drug Category: Antidiuretic hormone replacement -- These agents are used for the replacement of vasopressin.
Drug Name
Vasopressin (Pitressin) -- IM or SC injection of ADH analog that has vasopressor and ADH activity. Increases water resorption at distal renal tubular epithelium (ADH effect). Promotes smooth-muscle contraction throughout vascular bed of renal tubular epithelium (vasopressor effects).
Adult Dose5-10 U IM/SC q6h
Pediatric Dose2.5-10 U IM/SC bid/qid
ContraindicationsDocumented hypersensitivity; coronary artery disease
InteractionsLithium, epinephrine, demeclocycline, heparin, and alcohol may decrease effects; chlorpropamide, urea, fludrocortisone, and carbamazepine may potentiate effects
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsCaution in cardiovascular disease, seizure disorders, nitrogen retention, asthma, or migraine; excessive doses may result in hyponatremia
Drug Name
Desmopressin acetate (DDAVP, Stimate) -- Longer-acting ADH derivative that can be used intranasally; increases cellular permeability of collecting ducts, resulting in resorption of water by kidneys.
Adult Dose150 mcg intranasally q12-24h; endocrinologist should follow effects to adjust dose and timing
Pediatric Dose<3 months: Not established
3 months to 12 years: 5-30 mcg/d intranasally qd or divided bid
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; patients with platelet-type von Willebrand disease
InteractionsDemeclocycline and lithium decrease effects; fludrocortisone and chlorpropamide increase effects
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsAvoid overhydration in patients using desmopressin to benefit from its hemostatic effects
  FOLLOW-UP Section 8 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Further Inpatient Care:

In/Out Patient Meds:

Complications:

Prognosis:

Patient Education:

  MISCELLANEOUS Section 9 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Medical/Legal Pitfalls:

  • Missing a diagnosis of hypopituitarism can be lethal for the patient who does not receive appropriate hormone replacement
  • Failure to consider a hypopituitary condition in the patient with neuropsychiatric disturbances, cognitive impairment, disturbed sleep patterns, personality change, loss of affect, and visual and auditory hallucinations, particularly following subdural hemorrhage
  BIBLIOGRAPHY Section 10 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

  • Abboud CF: Anterior pituitary failure. In: The Pituitary. 2nd ed. 2002: 349-404.
  • Abboud, CF: Hypopituitarism. In: Conn RB, ed: Current Diagnosis. 8th Ed. 1991: 811-19.
  • Arafah BM, Nasrallah MP: Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001 Dec; 8(4): 287-305[Medline].
  • Baldelli R, Bellone S, Corneli G: Traumatic brain injury-induced hypopituitarism in adolescence. Pituitary 2005; 8(3-4): 255-7[Medline].
  • Benvenga S: Brain injury and hypopituitarism: the historical background. Pituitary 2005; 8(3-4): 193-5[Medline].
  • Blondell RD: Hypopituitarism. Am Fam Physician 1991 Jun; 43(6): 2029-36[Medline].
  • Bulow B, Hagmar L, Eskilsson J: Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 2000 Feb; 85(2): 574-84[Medline].
  • Chang YC, Tsai JC, Tseng FY: Neuropsychiatric disturbances and hypopituitarism after traumatic brain injury in an elderly man. J Formos Med Assoc 2006 Feb; 105(2): 172-6[Medline].
  • Darzy KH, Shalet SM: Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005; 8(3-4): 203-11[Medline].
  • Giordano G, Aimaretti G, Ghigo E: Variations of pituitary function over time after brain injuries: the lesson from a prospective study. Pituitary 2005; 8(3-4): 227-31[Medline].
  • Guyton, AC, Hall JE: The pituitary hormones and their control by the hypothalamus. In: Textbook of Medical Physiology. 11th ed. 2005: 846-856.
  • Insel JR, Dhanjal N: Pituitary infarction resulting from intranasal cocaine abuse. Endocr Pract 2004 Nov-Dec; 10(6): 478-82[Medline].
  • Kreitschmann-Andermahr I: Subarachnoid hemorrhage as a cause of hypopituitarism. Pituitary 2005; 8(3-4): 219-25[Medline].
  • Landman RE, Wardlaw SL, McConnell RJ: Pituitary lymphoma presenting as fever of unknown origin. J Clin Endocrinol Metab 2001 Apr; 86(4): 1470-6[Medline].
  • Lanes R: Metabolic abnormalities in growth hormone deficiency. Pediatr Endocrinol Rev 2004 Dec; 2(2): 209-15[Medline].
  • Lin SH, Hung YH, Lin YF: Severe hyponatremia as the presenting feature of clinically non-functional pituitary adenoma with hypopituitarism. Clin Nephrol 2002 Jan; 57(1): 85-8[Medline].
  • Masel BE: Traumatic brain injury induced hypopituitarism: the need and hope of rehabilitation. Pituitary 2005; 8(3-4): 263-6[Medline].
  • McArthur RG, Morgan K, Phillips JA: The natural history of familial hypopituitarism. Am J Med Genet 1985 Nov; 22(3): 553-66[Medline].
  • Minniti G, Esposito V, Piccirilli M: Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol 2005 Dec; 153(6): 723-35[Medline].
  • Moll GW, Bock HG: Two tumors detected by thyroid assessment in two children. Endocr Pract 2001 Nov-Dec; 7(6): 467-73[Medline].
  • Ozkan Y, Colak R: Sheehan syndrome: clinical and laboratory evaluation of 20 cases. Neuro Endocrinol Lett 2005 Jun; 26(3): 257-60[Medline].
  • Pivnick EK, Burstein S, Wilroy RS: Hallermann-Streiff syndrome with hypopituitarism contributing to growth failure. Am J Med Genet 1991 Dec 15; 41(4): 503-7[Medline].
  • Popovic V: GH Deficiency as The Most Common Pituitary Defect After TBI: Clinical Implications. Pituitary 2005; 8(3-4): 239-43[Medline].
  • Reynaud R, Chadli-Chaieb M, Vallette-Kasic S: A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J Clin Endocrinol Metab 2004 Nov; 89(11): 5779-86[Medline].
  • Schneider HJ, Schneider M, Saller B: Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 2006 Feb; 154(2): 259-65[Medline].
  • Sert M, Tetiker T, Kirim S: Clinical report of 28 patients with Sheehan's syndrome. Endocr J 2003 Jun; 50(3): 297-301[Medline].
  • Somali MH, Anastasiou AL, Goulis DG: Pituitary abscess presenting with cranial nerve paresis. Case report and review of literature. J Endocrinol Invest 2001 Jan; 24(1): 45-50[Medline].
  • Tanriverdi F, Senyurek H, Unluhizarci K: High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and at 12-months after the trauma. J Clin Endocrinol Metab 2006 Mar 7;[Medline].
  • Tindall GT, Barrow DL: Pituitary deficiency states. In: Disorders of the Pituitary.Vol 1 1986: 451-72.
  • van Aken MO, Lamberts SW: Diagnosis and treatment of hypopituitarism: an update. Pituitary 2005; 8(3-4): 183-91[Medline].
  • Vance ML: Hypopituitarism [published erratum appears in N Engl J Med 1994 Aug 18;331(7):487]. N Engl J Med 1994 Jun 9; 330(23): 1651-62[Medline].
  • Wass J.A.H., Besser GM, DeGroot LJ: Tests of Pituitary Function. Endocrinology 1989; 1: 491-7.
  • Williams HR, Oliver NS, Murphy F: The role of the biochemistry department in the diagnosis of pituitary apoplexy. Ann Clin Biochem 2004 Mar; 41(Pt 2): 162-5[Medline].

Hypopituitarism excerpt